Euronext N.V. (FRA:ENX)
Germany · Delayed Price · Currency is EUR 28.00
-0.40 (-1.41%)
Last updated: Aug 1, 2025
CTI BioPharma Cash Flow Statement
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | -9 - -5 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | -9 - -5 |
Net Income | - | 585.57 | 513.57 | 437.83 | 413.34 | 315.48 | Upgrade |
Depreciation & Amortization | - | 108.43 | 108.45 | 106.86 | 92.33 | 37.76 | Upgrade |
Other Amortization | - | 80.31 | 61.68 | 53.33 | 42.25 | 20.02 | Upgrade |
Loss (Gain) From Sale of Investments | - | -1.18 | -53.03 | - | - | - | Upgrade |
Loss (Gain) on Equity Investments | - | -33.49 | -30.03 | -18.67 | -7.44 | -8.92 | Upgrade |
Stock-Based Compensation | - | 15.55 | 14.38 | 13.99 | 10.39 | 8.52 | Upgrade |
Other Operating Activities | - | 42.94 | 55.56 | -44.22 | -48.23 | 12.14 | Upgrade |
Change in Other Net Operating Assets | - | -89.54 | 155.5 | 67.37 | 41.06 | -107.01 | Upgrade |
Operating Cash Flow | - | 708.6 | 826.07 | 616.49 | 543.71 | 277.99 | Upgrade |
Operating Cash Flow Growth | - | -14.22% | 34.00% | 13.39% | 95.59% | 9.54% | Upgrade |
Capital Expenditures | - | -17.96 | -27.7 | -31.87 | -33.37 | -6.65 | Upgrade |
Sale of Property, Plant & Equipment | - | - | - | 0.05 | - | 0.1 | Upgrade |
Cash Acquisitions | - | -65.17 | - | -65.99 | -4,196 | -80.36 | Upgrade |
Divestitures | - | - | -0.21 | 8.74 | 5.88 | - | Upgrade |
Sale (Purchase) of Intangibles | - | -69.28 | -75.33 | -67.65 | -34.22 | -12.57 | Upgrade |
Investment in Securities | - | 36.26 | 204.57 | 11.65 | 9.77 | -14.77 | Upgrade |
Other Investing Activities | - | 79.09 | 56.58 | 22.48 | 32.41 | 9.52 | Upgrade |
Investing Cash Flow | - | -37.07 | 157.91 | -122.59 | -4,216 | -104.73 | Upgrade |
Long-Term Debt Issued | - | - | - | - | 5,472 | 255.86 | Upgrade |
Long-Term Debt Repaid | - | -20.77 | -28.42 | -23.42 | -3,787 | -14.89 | Upgrade |
Net Debt Issued (Repaid) | - | -20.77 | -28.42 | -23.42 | 1,685 | 240.97 | Upgrade |
Issuance of Common Stock | - | - | - | - | 2,375 | - | Upgrade |
Repurchase of Common Stock | - | -108.3 | -220.03 | -3.58 | -36.97 | -15.05 | Upgrade |
Common Dividends Paid | - | -257.27 | -237.19 | -205.99 | -157.17 | -110.62 | Upgrade |
Other Financing Activities | - | -55.34 | -36.57 | -49.38 | -27.09 | -11.06 | Upgrade |
Financing Cash Flow | - | -441.67 | -522.21 | -282.37 | 3,839 | 104.24 | Upgrade |
Foreign Exchange Rate Adjustments | - | -5.19 | -14.06 | -19.86 | 12.66 | -17.85 | Upgrade |
Net Cash Flow | - | 224.67 | 447.71 | 191.67 | 179.94 | 259.65 | Upgrade |
Free Cash Flow | - | 690.63 | 798.37 | 584.62 | 510.34 | 271.34 | Upgrade |
Free Cash Flow Growth | - | -13.49% | 36.56% | 14.56% | 88.08% | 13.48% | Upgrade |
Free Cash Flow Margin | - | 42.45% | 54.14% | 41.21% | 39.30% | 30.68% | Upgrade |
Free Cash Flow Per Share | - | 6.64 | 7.50 | 5.47 | 5.30 | 3.88 | Upgrade |
Cash Interest Paid | - | 29.43 | 28.71 | 29.57 | 16.07 | 11.56 | Upgrade |
Cash Income Tax Paid | - | 210.55 | 129.99 | 220.64 | 215.61 | 114.82 | Upgrade |
Levered Free Cash Flow | - | 590.29 | 698.31 | 464.63 | 478.14 | 325.45 | Upgrade |
Unlevered Free Cash Flow | - | 613.11 | 720.62 | 487.95 | 503.77 | 336.43 | Upgrade |
Change in Net Working Capital | - | 27.86 | -198.09 | -1.51 | -27.44 | -0.43 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.